Literature DB >> 28878077

IRF9 Prevents CD8+ T Cell Exhaustion in an Extrinsic Manner during Acute Lymphocytic Choriomeningitis Virus Infection.

Magdalena Huber1, Tamara Suprunenko2, Thomas Ashhurst3, Felix Marbach4, Hartmann Raifer4, Svenja Wolff5, Thomas Strecker5, Barney Viengkhou2, So Ri Jung2, Hannah-Lena Obermann6, Stefan Bauer6, Haifeng C Xu7, Philipp A Lang7, Adomati Tom8, Karl S Lang8, Nicholas J C King3, Iain L Campbell9, Markus J Hofer10,11.   

Abstract

Effective CD8+ T cell responses play an important role in determining the course of a viral infection. Overwhelming antigen exposure can result in suboptimal CD8+ T cell responses, leading to chronic infection. This altered CD8+ T cell differentiation state, termed exhaustion, is characterized by reduced effector function, upregulation of inhibitory receptors, and altered expression of transcription factors. Prevention of overwhelming antigen exposure to limit CD8+ T cell exhaustion is of significant interest for the control of chronic infection. The transcription factor interferon regulatory factor 9 (IRF9) is a component of type I interferon (IFN-I) signaling downstream of the IFN-I receptor (IFNAR). Using acute infection of mice with lymphocytic choriomeningitis virus (LCMV) strain Armstrong, we show here that IRF9 limited early LCMV replication by regulating expression of interferon-stimulated genes and IFN-I and by controlling levels of IRF7, a transcription factor essential for IFN-I production. Infection of IRF9- or IFNAR-deficient mice led to a loss of early restriction of viral replication and impaired antiviral responses in dendritic cells, resulting in CD8+ T cell exhaustion and chronic infection. Differences in the antiviral activities of IRF9- and IFNAR-deficient mice and dendritic cells provided further evidence of IRF9-independent IFN-I signaling. Thus, our findings illustrate a CD8+ T cell-extrinsic function for IRF9, as a signaling factor downstream of IFNAR, in preventing overwhelming antigen exposure resulting in CD8+ T cell exhaustion and, ultimately, chronic infection.IMPORTANCE During early viral infection, overwhelming antigen exposure can cause functional exhaustion of CD8+ T cells and lead to chronic infection. Here we show that the transcription factor interferon regulatory factor 9 (IRF9) plays a decisive role in preventing CD8+ T cell exhaustion. Using acute infection of mice with LCMV strain Armstrong, we found that IRF9 limited early LCMV replication by regulating expression of interferon-stimulated genes and Irf7, encoding a transcription factor crucial for type I interferon (IFN-I) production, as well as by controlling the levels of IFN-I. Infection of IRF9-deficient mice led to a chronic infection that was accompanied by CD8+ T cell exhaustion due to defects extrinsic to T cells. Our findings illustrate an essential role for IRF9, as a mediator downstream of IFNAR, in preventing overwhelming antigen exposure causing CD8+ T cell exhaustion and leading to chronic viral infection.
Copyright © 2017 American Society for Microbiology.

Entities:  

Keywords:  CD8+ T cell exhaustion; interferon regulatory factor 9; lymphocytic choriomeningitis virus; type I interferon

Mesh:

Substances:

Year:  2017        PMID: 28878077      PMCID: PMC5660491          DOI: 10.1128/JVI.01219-17

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  51 in total

1.  Type-I IFN drives the differentiation of short-lived effector CD8+ T cells in vivo.

Authors:  Melanie Wiesel; Josh Crouse; Gregor Bedenikovic; Andrew Sutherland; Nicole Joller; Annette Oxenius
Journal:  Eur J Immunol       Date:  2011-12-20       Impact factor: 5.532

Review 2.  Regulation of antiviral T cell responses by type I interferons.

Authors:  Josh Crouse; Ulrich Kalinke; Annette Oxenius
Journal:  Nat Rev Immunol       Date:  2015-03-20       Impact factor: 53.106

3.  Tolerance induction in double specific T-cell receptor transgenic mice varies with antigen.

Authors:  H Pircher; K Bürki; R Lang; H Hengartner; R M Zinkernagel
Journal:  Nature       Date:  1989-11-30       Impact factor: 49.962

4.  IFIT2 is an effector protein of type I IFN-mediated amplification of lipopolysaccharide (LPS)-induced TNF-α secretion and LPS-induced endotoxin shock.

Authors:  Alexandra Siegfried; Susanne Berchtold; Birgit Manncke; Eva Deuschle; Julia Reber; Thomas Ott; Michaela Weber; Ulrich Kalinke; Markus J Hofer; Bastian Hatesuer; Klaus Schughart; Valérie Gailus-Durner; Helmut Fuchs; Martin Hrabe de Angelis; Friedemann Weber; Mathias W Hornef; Ingo B Autenrieth; Erwin Bohn
Journal:  J Immunol       Date:  2013-09-06       Impact factor: 5.422

5.  Two interferon-induced nuclear factors bind a single promoter element in interferon-stimulated genes.

Authors:  D S Kessler; D E Levy; J E Darnell
Journal:  Proc Natl Acad Sci U S A       Date:  1988-11       Impact factor: 11.205

6.  Regulation of the promoter activity of interferon regulatory factor-7 gene. Activation by interferon snd silencing by hypermethylation.

Authors:  R Lu; W C Au; W S Yeow; N Hageman; P M Pitha
Journal:  J Biol Chem       Date:  2000-10-13       Impact factor: 5.157

7.  Blockade of chronic type I interferon signaling to control persistent LCMV infection.

Authors:  Elizabeth B Wilson; Douglas H Yamada; Heidi Elsaesser; Jonathan Herskovitz; Jane Deng; Genhong Cheng; Bruce J Aronow; Christopher L Karp; David G Brooks
Journal:  Science       Date:  2013-04-12       Impact factor: 47.728

Review 8.  Regulation of type I interferon responses.

Authors:  Lionel B Ivashkiv; Laura T Donlin
Journal:  Nat Rev Immunol       Date:  2014-01       Impact factor: 53.106

9.  RUNX2 Mediates Plasmacytoid Dendritic Cell Egress from the Bone Marrow and Controls Viral Immunity.

Authors:  Michaël Chopin; Simon P Preston; Aaron T L Lun; Julie Tellier; Gordon K Smyth; Marc Pellegrini; Gabrielle T Belz; Lynn M Corcoran; Jane E Visvader; Li Wu; Stephen L Nutt
Journal:  Cell Rep       Date:  2016-04-14       Impact factor: 9.423

10.  Type I interferons directly inhibit regulatory T cells to allow optimal antiviral T cell responses during acute LCMV infection.

Authors:  Shivani Srivastava; Meghan A Koch; Marion Pepper; Daniel J Campbell
Journal:  J Exp Med       Date:  2014-04-07       Impact factor: 14.307

View more
  15 in total

Review 1.  Type I interferon signaling, regulation and gene stimulation in chronic virus infection.

Authors:  Sabelo Lukhele; Giselle M Boukhaled; David G Brooks
Journal:  Semin Immunol       Date:  2019-05-30       Impact factor: 11.130

2.  EZH1 repression generates mature iPSC-derived CAR T cells with enhanced antitumor activity.

Authors:  Ran Jing; Irene Scarfo; Mohamad Ali Najia; Edroaldo Lummertz da Rocha; Areum Han; Michael Sanborn; Trevor Bingham; Caroline Kubaczka; Deepak K Jha; Marcelo Falchetti; Thorsten M Schlaeger; Trista E North; Marcela V Maus; George Q Daley
Journal:  Cell Stem Cell       Date:  2022-08-04       Impact factor: 25.269

Review 3.  T-Cell Exhaustion in Chronic Infections: Reversing the State of Exhaustion and Reinvigorating Optimal Protective Immune Responses.

Authors:  Alireza Saeidi; Keivan Zandi; Yi Ying Cheok; Hamidreza Saeidi; Won Fen Wong; Chalystha Yie Qin Lee; Heng Choon Cheong; Yean Kong Yong; Marie Larsson; Esaki Muthu Shankar
Journal:  Front Immunol       Date:  2018-11-09       Impact factor: 7.561

Review 4.  Complexities of Type I Interferon Biology: Lessons from LCMV.

Authors:  Tamara Suprunenko; Markus J Hofer
Journal:  Viruses       Date:  2019-02-20       Impact factor: 5.048

5.  Multi-pathway Protective Effects of MicroRNAs on Human Chondrocytes in an In Vitro Model of Osteoarthritis.

Authors:  Rua Nader Al-Modawi; Jan E Brinchmann; Tommy A Karlsen
Journal:  Mol Ther Nucleic Acids       Date:  2019-07-26       Impact factor: 8.886

6.  Contribution of STAT1 to innate and adaptive immunity during type I interferon-mediated lethal virus infection.

Authors:  So Ri Jung; Thomas M Ashhurst; Phillip K West; Barney Viengkhou; Nicholas J C King; Iain L Campbell; Markus J Hofer
Journal:  PLoS Pathog       Date:  2020-04-20       Impact factor: 6.823

7.  Identification and validation of a prognostic signature and combination drug therapy for immunotherapy of head and neck squamous cell carcinoma.

Authors:  Weijie Qiang; Yifei Dai; Xiaoyan Xing; Xiaobo Sun
Journal:  Comput Struct Biotechnol J       Date:  2021-02-09       Impact factor: 7.271

Review 8.  Exhausted T cells and epigenetic status.

Authors:  Ziqing Zeng; Feng Wei; Xiubao Ren
Journal:  Cancer Biol Med       Date:  2020-12-15       Impact factor: 4.248

Review 9.  Viral infections in humans and mice with genetic deficiencies of the type I IFN response pathway.

Authors:  Isabelle Meyts; Jean-Laurent Casanova
Journal:  Eur J Immunol       Date:  2021-04-04       Impact factor: 5.532

Review 10.  Interferon Regulatory Factor 9 Structure and Regulation.

Authors:  Alvin Paul; Thean Hock Tang; Siew Kit Ng
Journal:  Front Immunol       Date:  2018-08-10       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.